Spyre Therapeutics
SYRE
#5743
Rank
โ‚น72.70 B
Marketcap
โ‚น1,206
Share price
-5.36%
Change (1 day)
-55.41%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -โ‚น17.56 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚น10.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น17.81 Billion62.23%
2023 -โ‚น10.98 Billion51.64%
2022 -โ‚น7.24 Billion29.14%
2021 -โ‚น5.61 Billion-19.43%
2020 -โ‚น6.96 Billion1.43%
2019 -โ‚น6.86 Billion76.7%
2018 -โ‚น3.89 Billion64.27%
2017 -โ‚น2.37 Billion26.34%
2016 -โ‚น1.87 Billion93.6%
2015 -โ‚น0.97 Billion27.08%
2014 -โ‚น0.77 Billion